Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,396
Closed -$14.8K 5463
2022
Q4
$14.8K Sell
15,396
-9,360
-38% -$13.2K ﹤0.01% 4412
2022
Q3
$54K Buy
+24,756
New +$85.4K ﹤0.01% 4224
2022
Q2
Sell
-11,921
Closed -$60K 5722
2022
Q1
$60K Sell
11,921
-6,725
-36% -$34.1K ﹤0.01% 4450
2021
Q4
$117K Buy
+18,646
New +$127K ﹤0.01% 4289
2021
Q3
Sell
-4,231
Closed -$32K 5778
2021
Q2
$32K Buy
+4,231
New +$29.5K ﹤0.01% 4744
2015
Q4
Sell
-18
Closed 5736
2015
Q3
$0 Buy
+18
New +$437 ﹤0.01% 5549

Other funds holding VXRT

Walleye Trading's VXRT Position: Q1 2023 in Review

Walleye Trading sold out of Vaxart (VXRT) in Q1 2023, closing a stake of 15,396 shares — an estimated $14.8K sold.

Walleye Trading first reported a position in VXRT in Q3 2015 and held it in 6 quarters. The position peaked at $117K in Q4 2021. 109 funds tracked by Wall St. Rank hold VXRT as of Q1 2023.

  • Walleye Trading reported no remaining Vaxart position as of Q1 2023 after selling out during the quarter.
  • Walleye Trading sold 15,396 Vaxart shares in Q1 2023, an estimated $14.8K.
  • Walleye Trading first reported a position in Vaxart in Q3 2015 and held it in 6 quarters.
  • Walleye Trading's Vaxart position peaked at $117K in Q4 2021.
  • 109 funds tracked by Wall St. Rank held Vaxart as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.